![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/107 | |
A61K 9/28 | |||
A61K 9/51 | |||
A61K 38/06 | |||
A61K 45/06 |
(11) | Number of the document | 2001400 |
(13) | Kind of document | T |
(96) | European patent application number | 07753175.4 |
Date of filing the European patent application | 2007-03-14 | |
(97) | Date of publication of the European application | 2008-12-17 |
(45) | Date of publication and mention of the grant of the patent | 2014-05-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/006528 |
Date | 2007-03-14 |
(87) | Number | WO 2007/106555 |
Date | 2007-09-20 |
(30) | Number | Date | Country code |
782148 P | 2006-03-14 | US |
(72) |
WEN, Jingyuan, NZ
THOMAS, Gregory Brian, AU
BICKERDIKE, Mike John, NZ
|
(73) |
Neuren Pharmaceuticals Limited,
Level 1, 59 Wellington Street Freemans Bay, Auckland 1011,
NZ
Wen, Jingyuan, 94 Harold Street, Mt. Eden, NZ Thomas, Gregory Brian, 10 Grangemouth Turn, Kinross,, Perth WA 6028, AU Bickerdike, Mike John, 41 Waimarie Street, St. Heliers, Auckland, NZ |
(54) | ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE |
ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE |